Brief: Santhera Secures Additional Funding Through A Private Placement Of Shares

Santhera Pharmaceuticals Holding AG

28/02/2023 06:18

Feb 28 (Reuters) - Santhera Pharmaceuticals Holding AG
 SANN.S :
    * SANTHERA SECURES ADDITIONAL FUNDING THROUGH A PRIVATE
PLACEMENT
OF SHARES AND UPSIZING OF EXISTING FINANCING ARRANGEMENT
    * SANTHERA - SANTHERA WILL ISSUE 40 MILLION SHARES, 37
MILLION OF
WHICH IT WILL HOLD IN TREASURY FOR THE TIME BEING
    * SANTHERA - FUNDING INTENDED TO SUPPORT COMPANY THROUGH FDA
DECISION ON VAMOROLONE IN DMD
    * SANTHERA - COMPANY FORMS STRATEGY COMMITTEE OF BOARD AND
MANAGEMENT
    * SANTHERA - AMENDMENT OF ITS EXISTING FINANCING ARRANGEMENT
WITH
FUNDS MANAGED BY HIGHBRIDGE CAPITAL MANAGEMENT TO PROVIDE UP TO
CHF 22.2 MILLION
    * SANTHERA - SANTHERA WILL NOMINATE BRADLEY MEYER, SENIOR
ADVISOR
AT DUCERA PARTNERS, AS A NEW BOARD MEMBER
    * SANTHERA - SANTHERA WILL FORM A STRATEGY COMMITTEE TO
EVALUATE
ALL STRATEGIC OPTIONS FOR THE COMPANY WITH A PRIMARY FOCUS ON
BRINGING VAMOROLONE
    * SANTHERA - UPON COMPLETION OF ORDINARY CAPITAL INCREASE,
CO WILL
EXCEED MANDATORY OFFER THRESHOLD OF 33 1/3% OF VOTING RIGHTS FOR
SHORT PERIOD OF TIME

Source text for Eikon:  ID:nGNE7GmVt6 
Further company coverage:  SANN.S 

 ((Reuters.Briefs@thomsonreuters.com;))